英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
gonfiezza查看　gonfiezza　在百度字典中的解释百度英翻中〔查看〕
gonfiezza查看　gonfiezza　在Google字典中的解释Google英翻中〔查看〕
gonfiezza查看　gonfiezza　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home Page | LITFULO® (ritlecitinib) | Safety Info
    LITFULO (ritlecitinib) is a prescription medicine used to treat severe alopecia areata in adults and adolescents 12 years and older
  • Litfulo: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Litfulo (ritlecitinib) and Olumiant (baricitinib) are both oral medications that may be used to treat certain autoimmune conditions Olumiant is a Janus kinase (JAK) inhibitor, and Litfulo inhibits JAK3 and the TEC kinase family
  • LITFULO- ritlecitinib capsule - Pfizer
    LITFULO (ritlecitinib) capsules are formulated with ritlecitinib tosylate, a kinase inhibitor Ritlecitinib tosylate is a white to off white to pale pink solid which is freely soluble in water
  • label - Food and Drug Administration
    LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older (1) Limitations of Use: Not recommended for use in combination with other JAK • For dosage interruption for certain adverse reactions, see Full Prescribing Information (2 4)
  • Litfulo (ritlecitinib): Uses, Side Effects, Interactions . . . - WebMD
    Find patient medical information for Litfulo (ritlecitinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
  • Home | LITFULO® (ritlecitinib) capsules HCP Site | Safety Info
    Discover LITFULO®, the only FDA-approved treatment for severe alopecia areata in both adults and adolescents as young as 12 See safety info
  • Ritlecitinib: First Approval - PMC
    Ritlecitinib (LITFULO™), an orally administered kinase inhibitor, is being developed by Pfizer for the treatment of alopecia areata, vitiligo, ulcerative colitis and Crohn’s disease On 23 June 2023, ritlecitinib received approval in the USA for the
  • LITFULO® (ritlecitinib) What is the most important . . . - Medical
    LITFULO® (ritlecitinib) What is the most important information I should know about LITFULO? What is the most important information I should know about LITFULO? LITFULO may cause serious side effects, including: 1 Serious infections LITFULO is a medicine that affects your immune system LITFULO can lower the ability of your immune system to fight medication page for patients to search for
  • Safety Side Effects | LITFULO (ritlecitinib) | Safety Info
    Learn important info about potential side effects for LITFULO® and safety for this once-daily prescription for people ages 12+ with severe alopecia areata
  • LITFULO (ritlecitinib) FAQ - National Alopecia Areata Foundation - NAAF
    LITFULO (ritlecitinib) FAQ Click to download the LITFULO FAQ What is LITFULO? LITFULO (Ritlecitnib) is a selective dual Janus kinase 3 (JAK3) and tyrosine protein (TEC) kinase inhibitor approved by the U S Food and Drug Administration (FDA) for adults and adolescents 12 years and older with severe alopecia areata (AA) (1)





中文字典-英文字典  2005-2009